OGN Organon & Co.
Price Chart
Executive Summary
Organon management filed this DEFA14A to communicate with employees following the definitive merger agreement with Sun Pharma at $14.00/share (103% premium). The letter emphasizes leadership continuity and operational focus, seeking support for the transaction which is subject to shareholder vote and regulatory approvals.
Actionable Insight
The deal premium is locked, so upside is limited to spread tightening. Monitor for competing bids, regulatory hurdles, and the shareholder vote timeline. Trading near the buyout price suggests high confidence in closing.
Key Facts
- Definitive merger agreement with Sun Pharma at $14.00 per share in cash
- Enterprise value of approximately $11.75 billion
- 103% premium to unaffected stock price
- Permanent CEO Joseph Morrissey and Executive Chair Carrie Cox to continue
- Transaction subject to shareholder approval and regulatory clearances
Financial Impact
Shareholders to receive $14.00 per share cash, representing a 103% premium and enterprise value of $11.75B
Risk Factors
- Rival bid or shareholder opposition
- Regulatory delays or rejection
- Failure to obtain required financing or approvals
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-182416 |
| Document: 0001193125-26-182416-index-headers.html | 0001193125-26-182416 |
| Document: 0001193125-26-182416-index.html | 0001193125-26-182416 |
| Document: 0001193125-26-182416.txt | 0001193125-26-182416 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
PREM14A
| $13.37 $13.36 | ▼ −0.04% | ▲ +2.71% | $13.39 (+0.19%) |
|
Apr 30, 2026
5w ago
|
DEFA14A
| $13.25 $13.31 | ▲ +0.45% | ▼ −1.27% | $13.39 (+1.09%) |
|
Apr 30, 2026
5w ago
|
8-K
| $13.25 $13.31 | ▼ −0.45% | ▲ +1.27% | $13.39 (−1.09%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.32 $13.26 | ▼ −0.41% | ▼ −2.10% | $13.39 (+0.56%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.32 $13.26 | ▼ −0.41% | ▼ −2.10% | $13.39 (+0.56%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Apr 27, 2026
6w ago
|
8-K
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Apr 24, 2026
6w ago
|
DEFA14A
| $13.16 $13.26 | ▲ +0.76% | ▲ +0.36% | $13.39 (+1.79%) |
|
Mar 6, 2026
13w ago
|
Court Ruling
| $6.56 $6.34 | ▼ −3.36% | ▼ −1.83% | $13.39 (+104.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access